The incidence of hypertensive disorders of pregnancy is 8% and this forms one of the deadly triads along with hemorrhage and jaundice which result in maternal death. According to WHO severe preeclampsia accounts for 16.1% of maternal deaths in developed countries over the past 2 decades.
INTRODUCTION
The incidence of hypertensive disorders of pregnancy is 8% and this forms one of the deadly triads along with hemorrhage and jaundice which result in maternal death. According to WHO severe preeclampsia accounts for 16 .1% of maternal deaths in developed countries over the past 2 decades. 1 
Setting

Tertiary teaching hospital
METHODS
Inclusion criteria
Over one year period all women with singleton pregnancies and early onset severe pre eclampsia where both mother and fetus were otherwise stable were included in the study.
Exclusion criteria
Any major maternal or fetal complications.
The definition of hypertension and proteinuria were those accepted by the international society for the study of hypertension in pregnancy. The women thus identified were admitted into the intensive care labor ward for noninvasive monitoring of maternal status.
Assessment of maternal and fetal status
Gestation was estimated by last menstrual period, obstetric USG or both.
Maternal monitoring was done by 4 hourly BP chart, urine protein examination daily and clinical examination daily, and other relevant investigations every 2 days.
The fetus was monitored by daily fetal monitoring, NST on alternate days, USG with Doppler and BPP every week. The data obtained were expressed as mean with standard deviation and median with range. Difference in mean were analysed the chi square test was applied to quantitative variables. P value <0.05 was taken as significant. The study was compared for analysis with other studies.
RESULTS
During 1 year period 17585 women delivered in the hospital. The youngest woman enrolled in the study was of 18 yrs and oldest 37 yrs. In women recruited in the study after expectant management the mean and median number of days gained by women antepartum was 16.7 and 14.2 days respectively. Only 5% (n=6) went in for spontaneous delivery. 95% were induced with dinoprost gel (n=99).
Of these 15% (n=16) the fetus had died in utero. There were 11 cases (10%) still birth and 78 live born Vaginal delivery was achieved in 90 cases (85.5%) and rest 15 (14.5%) LSCS was done. From the above table it is seen that most of the complications occurs after 30 weeks of gestation. There was no death reported. When chi square test was applied this was found to be significant.
DISCUSSION
The incidence of hypertensive disorders of pregnancy is 8%. These form one of the deadly triads along with hemorrhage and jaundice that result in maternal death. According to WHO severe preeclampsia accounts for 16.1% of maternal deaths in developed countries over the past 2 decades. 
Complications and management
Severe preeclampsia (SPE) is a complex disease with a chronologically unpredictable and progressively deteriorating course. Traditional management has included expedited delivery as the ultimate cure for SPE, aimed at preventing potential end-organ effects. Serious maternal complications of SPE include eclampsia, placental abruption, DIC, renal failure, hepatic hematoma or rupture, pulmonary edema, ARDS, retinal detachment, myocardial infarction, pancreatitis, stroke, and death. The current standard of care, therefore, includes prompt delivery of patients with SPE if the disease develops at or after 34 weeks' GA. 21 
Early onset SPE
A clinical conundrum arises in the 0.3% of pregnancies in which SPE develops before 34 weeks' GA. 22 The decision to deliver at early GA requires weighing the risks of iatrogenic prematurity against the risks of prolonging the pregnancy. Numerous authors have suggested varying degrees of expectant management to improve perinatal outcomes. This discussion involves the rationale for expectant management, ideal candidates, contraindications, indications for delivery, and recommendations regarding the mode of delivery.
Rationale of expectant management
Given the difficulty in balancing potential maternal morbidity associated with expectant management of SPE remote from term and the risks of an iatrogenic premature birth, definitive recommendations are limited by the paucity of adequately powered, randomized, controlled trials. Only a few randomized trials have been reported. 20, 21 Each study reported improved perinatal outcomes with minimal maternal morbidity. Odendaal and colleagues randomized 38 women with SPE (defined by BP criterion only) who were between 28 and 34 weeks of gestation to immediate delivery after antenatal corticosteroid administration (n=20) or expectant management (n=18). 20 Mean prolongation of pregnancy in the expectant management group was 7.1 days (P<0.05), with no increase in maternal complications.
In Sibai and associates' study of 95 patients with early onset SPE between 28 and 32 weeks (again diagnosed by BP criterion only), 46 patients were randomized to immediate delivery and 49 to expectant management. 21 Mean pregnancy prolongation was 15.4 days (range, 4-36 days), with no cases of eclampsia.
In a nonrandomized study by Sibai and colleagues, 109 patients with SPE in the second trimester were followed. 22 Expectant management with "aggressive" maternal and fetal surveillance was used for patients more than 24 and no more than 27 weeks' gestation (n=84), and termination was recommended for those no more than 24 weeks' gestation (n=25, with 10 undergoing termination and 15 electing to continue the pregnancy). Expectant management resulted in mean prolongation of pregnancy of 13.2 days (range, 4-28 days). There were no differences between the 2 groups with regard to maternal complications.
The afore mentioned studies showed that expectant management with aggressive monitoring of maternal status may improve the outcome in patients with early onset SPE, but judicious selection of candidates should be employed. [20] [21] [22] The ideal candidate for expectant management of preeclampsia is an appropriately counselled patient at least 24+0/7 weeks' and no more than 33+6/7 weeks' GA, with reassuring maternal and fetal status. 18 The lower limits of viability vary among institutions (22+0/7 to 24+0/7 weeks' GA). Counselling patients in the peri viable period should reflect these differences. The patient should be counselled on the likelihood of perinatal survival on the basis of GA, estimated fetal weight, gender, and individual institutional experiences, balanced against the risks of maternal complications. Candidates should be admitted to a tertiary care center with 24-hour availability of obstetricians, anesthesiologists, and a neonatal team. One study demonstrated that approximately 63% of women diagnosed with early onset SPE are eligible for expectant management using this criteria. 9 In our study most of the women were primi gravida this confirms with the widely considered hallmark of pre eclampsia. The finding that among the multi gravida there were significant women who had pre eclampsia in the previous pregnancy also confirm the common finding that there is 11-12% increase in the incidence of pre eclampsia once they get pre eclampsia in the first pregnancy. The pregnancy was prolonged by 16.7 days with a median of 14.2 days.
When the gestational age was less than 25 weeks, the mean gain in prolongation of pregnancy was 10 days. Thus when the women entered into the study at early gestational age the mean number of days gained was In the index study there were 38% maternal complications which is comparable to 27% in hall et al. 23 The control of BP was carefully applied with 2 or 3 drugs. There was no complication like intracerebral bleed (ICB). It should be noted that ICB is one of the important cause of maternal mortality in South Africa. There were no such complications reported by Hall et al. The occurrence of HELLP syndrome (2.8%) was lower than figure of 20% reported in the overview of HELLP.
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CONCLUSIONS
From the one year study, it was found that there was a gain of 16 days when the mother with early onset SPE was put in expectant management. The maternal complications were as per the international standards and there was no increase in mortality and morbidity of the mother. Hence it will be advantageous to put a patient with early onset severe pre eclampsia in expectant management rather than terminate the pregnancy immediately as the practice is now. But to obtain optimum outcome the selection of patients and maternal care in a tertiary care centre is preferable.
